Stay updated on Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.2 to v3.6.3, indicating a minor platform update. No study content or visible details were altered.
    Difference
    0.1%
    Check dated 2026-07-03T23:37:55.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2 instead of v3.6.0. This indicates an updated release of study documents or page content.
    Difference
    0.1%
    Check dated 2026-06-26T23:58:29.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page now indicates that the study is no longer recruiting participants, signaling that enrollment has closed. It also introduces new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Interventions/Treatment header formatting, plus a revision tag update to v3.6.0.
    Difference
    0.6%
    Check dated 2026-06-12T16:00:49.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing Revision: v3.5.4. This is an administrative update and does not alter the study information shown to users.
    Difference
    0.1%
    Check dated 2026-06-05T10:07:58.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing v3.5.3. This indicates a routine platform update that updates internal versioning rather than study information.
    Difference
    0.1%
    Check dated 2026-05-15T05:55:14.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The study's Indiana-based affiliation was updated from Indiana University School of Medicine to Indiana University, changing the credited institution in the collaborators/locations section. This reflects a broader institutional naming for the site and may affect how the record is identified in communications and databases.
    Difference
    0.2%
    Check dated 2026-05-08T03:23:58.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.